|
KLHL24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.30980000365855E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.80800000035586E-07 |
| Normal-vs-Stage2 |
3.33659999995906E-06 |
| Normal-vs-Stage3 |
5.43889999704561E-09 |
| Normal-vs-Stage4 |
1.48040000036431E-07 |
| Stage1-vs-Stage2 |
8.304800E-01 |
| Stage1-vs-Stage3 |
9.202100E-02 |
| Stage1-vs-Stage4 |
1.540760E-01 |
| Stage2-vs-Stage3 |
3.199800E-01 |
| Stage2-vs-Stage4 |
3.297200E-01 |
| Stage3-vs-Stage4 |
9.437800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.31279999888201E-08 |
| Normal-vs-AfricanAmerican |
1.100310E-02 |
| Normal-vs-Asian |
1.20239999956695E-07 |
| Caucasian-vs-AfricanAmerican |
1.541390E-01 |
| Caucasian-vs-Asian |
4.984800E-01 |
| AfricanAmerican-vs-Asian |
8.019800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.22850000020492E-07 |
| Normal-vs-Female |
3.02960000420072E-08 |
| Male-vs-Female |
5.940400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.41549999999047E-06 |
| Normal-vs-Age(41-60Yrs) |
1.25079946400319E-10 |
| Normal-vs-Age(61-80Yrs) |
5.00920000034988E-07 |
| Normal-vs-Age(81-100Yrs) |
2.257800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.849500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.145200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.896960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.263400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.869800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.671600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.417000E-03 |
| Classical-VS-Follicular |
4.240400E-01 |
| Classical-VS-Other |
1.456830E-01 |
| Classical-VS-Normal |
4.48520000029262E-07 |
| Tall-VS-Follicular |
2.521100E-03 |
| Tall-VS-Other |
7.951800E-02 |
| Tall-VS-Normal |
1.59159996293567E-09 |
| Follicular-VS-Other |
2.780600E-01 |
| Follicular-VS-Normal |
2.40219999999569E-05 |
| Other-VS-Normal |
3.141000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03930000050489E-07 |
| Normal-vs-N1 |
1.240360E-04 |
| N0-vs-N1 |
6.232000E-01 |
|
|
